Jan 08, 2019 7:30 am EST Heat Biologics Principal Investigator Selected to Deliver Oral Presentation of New HS-110 Interim Phase 2 Data at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Nov 26, 2018 7:00 am EST Heat Biologics to Participate in Panel Presentation at the Goldman Sachs Asia Pacific Healthcare Forum
Nov 15, 2018 8:00 am EST Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update
Oct 19, 2018 7:00 am EDT Heat Biologics CEO to Participate in Panel Presentation at The Cellular ''Living Drug'' Revolution Summit in New York City